Parkinson's Disease Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

For the main study group (people with Parkinson's who take immune-suppressing medication):

• People who have been diagnosed with Parkinson's disease according to recognised international diagnostic guidelines
• People who have been regularly taking immune-suppressing medication (at the correct dose and on a consistent schedule for the condition it is treating) for more than 12 months, taken by mouth, injection, or inhalation
• People who are willing and able to give formal consent to take part in the study

For the comparison group (people with Parkinson's who do not take immune-suppressing medication):

• People who have been diagnosed with Parkinson's disease according to recognised international diagnostic guidelines
• People who have no history of regularly taking immune-suppressing medications
• People who are willing and able to give formal consent to take part in the study

Who may not be able to join:

For the main study group:

• People who only take immune-suppressing medication occasionally or as needed, rather than on a regular, consistent schedule
• People who have been taking immune-suppressing medication for less than 12 months
• People whose underlying condition requiring immune-suppressing medication has not improved or has continued to worsen despite treatment

For both groups:

• People with advanced cancer, severe heart failure, severe kidney failure, an untreated autoimmune disease, active inflammation, or a condition that affects how the body absorbs or processes medication
• People who have dementia
• People who are unable to give formal consent to participate

Important: Always verify eligibility with the trial site directly before applying.